[Women with a very high risk of breast cancer: Contraceptives, hormonal replacement therapy use and personalized screening].

Femmes à très haut risque de cancer du sein : contraception, traitement hormonal substitutif et dépistage personnalisé.
Breast cancer Cancer du sein Contraception Contraceptives Dépistage Genetic predisposition Hormonal replacement therapy Prédisposition héréditaire Screening Traitement hormonal substitutif

Journal

Gynecologie, obstetrique, fertilite & senologie
ISSN: 2468-7189
Titre abrégé: Gynecol Obstet Fertil Senol
Pays: France
ID NLM: 101693805

Informations de publication

Date de publication:
05 2023
Historique:
received: 04 08 2022
revised: 05 03 2023
accepted: 06 03 2023
medline: 5 5 2023
pubmed: 17 3 2023
entrez: 16 3 2023
Statut: ppublish

Résumé

Women with a high family risk of breast cancer are those with an identified genetic predisposition or those who have a suggestive family history without an identified germinal mutation, particularly for BRCA1 and BRCA2. Among these women with a very high risk of breast cancer, the fear of a potentially increased risk of breast cancer linked to some hormonal contraceptives and to the use of hormone replacement therapy, in connection with the general population data collected in literature, has led to certain reluctance to prescribe them to these women. Moreover, confusion often sets due to poor knowledge of the literature. Furthermore, the monitoring procedures consist of breast screening and strategies of risk reduction, based on recent recommendations. In order to improve the gynaecological monitoring throughout their lives, we offer here a review based on an analysis of recent literature and of the recommendations concerning personalized screening, contraception and hormone replacement therapy among women with a very high risk of breast cancer free from this illness.

Identifiants

pubmed: 36924927
pii: S2468-7189(23)00053-3
doi: 10.1016/j.gofs.2023.03.001
pii:
doi:

Substances chimiques

Contraceptive Agents 0

Types de publication

English Abstract Journal Article

Langues

fre

Sous-ensembles de citation

IM

Pagination

275-283

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Auteurs

C Duffau (C)

Service de gynécologie obstétrique, hôpital Jacques Puel-Bourran, centre hospitalier de Rodez, avenue de l'Hôpital, 12000 Rodez, France. Electronic address: c.duffau@ch-rodez.fr.

A Weyl (A)

Service de chirurgie oncologique, CHU de Toulouse, institut universitaire du cancer Toulouse Oncopole, Toulouse, France.

A Gosset (A)

Service de ménopause et maladies osseuses métaboliques, CHU de Toulouse, hôpital Paule-de-Viguier, Toulouse, France.

F Tremollières (F)

Service de ménopause et maladies osseuses métaboliques, CHU de Toulouse, hôpital Paule-de-Viguier, Toulouse, France.

C Vaysse (C)

Service de chirurgie oncologique, CHU de Toulouse, institut universitaire du cancer Toulouse Oncopole, Toulouse, France.

F Dalenc (F)

Département d'oncologie médicale, institut Claudius-Regaud, institut universitaire du cancer Toulouse Oncopole, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH